Skip to main content
    A

    AbbVie Inc (ABBV)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $292.91
    -1.64 (-0.56%)

    Market Cap: $521.50B

    Last updated: Nov 17, 2026 at 4:41 PM ET

    AbbVie Inc (ABBV) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    AbbVie (ABBV) has a latest price of $292.91 on Nov 17, 2026, 3.3% below its 52-week high of $302.93. Its price rose 29.0% over the past 12 months. The month-end price rose 428.7% over the 10 years through Oct 2026, a compound annual rate of 18.1%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $294.89 in Oct 2026 and its lowest $55.78 in Oct 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ABBV with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ABBV.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 10.8%, and over 6 months it rose 38.0%. The month-end price rose 108.9% over the 3 years through Oct 2026, a compound annual rate of 27.8%.

    PeriodChange
    1 month+3.6%
    3 months+10.8%
    6 months+38.0%
    12 months+29.0%
    12 months, with dividends+32.1%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+108.9%+27.8%
    5 years+157.2%+20.8%
    10 years+428.7%+18.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 54.4%, and its weakest was 2018, when it fell 4.7%.

    YearCloseChange
    2026 through Oct 2026$294.89+29.1%
    2025$228.49+28.6%
    2024$177.70+14.7%
    2023$154.97-4.1%
    2022$161.61+19.4%
    2021$135.40+26.4%
    2020$107.15+21.0%
    2019$88.54-4.0%
    2018$92.19-4.7%
    2017$96.71+54.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 6.0% above its 50-day average of $276.31 and 22.3% above its 200-day average of $239.43.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$292.91
    52-week high$302.93-3.3%
    52-week low$188.25+55.6%
    50-day average$276.31+6.0%
    200-day average$239.43+22.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 20.7%.

    MeasureValue
    1-year beta-0.01
    Largest fall, 1 year-15.7%
    Largest fall, 3 years-20.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    AbbVie traded at 22.8x earnings at the end of 2025, against a 5-year median of 15.9x and a 10-year median of 12.5x.

    ABBV valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ABBV

    What is ABBV's 1-year price change?

    AbbVie's price rose 29.0% over the past 12 months. With dividends included, the 12-month total return was 32.1%.

    What is ABBV's 5-year price change?

    AbbVie's month-end price rose 157.2% over the 5 years through Oct 2026, a compound annual rate of 20.8%. These figures leave out dividends.

    What is ABBV's 52-week high and low?

    AbbVie's 52-week high is $302.93 and its 52-week low is $188.25. Its latest price of $292.91 on Nov 17, 2026 is 3.3% below the high.

    What is ABBV's beta?

    AbbVie's 1-year beta against the S&P 500 is -0.01, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 15.7%.

    Is the ABBV chart free?

    Yes. Advanced Charting for ABBV is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.